Stock NEWBRY NEWBURY PHARMACEUTICALS AB
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Newbury Pharmaceuticals AB

Equities

NEWBRY

SE0015244884

Market Closed - Nasdaq Stockholm
Other stock markets
 09:30:00 24/06/2024 pm IST 		5-day change 1st Jan Change
3.2 SEK -7.51% Intraday chart for Newbury Pharmaceuticals AB -0.62% +4.23%
10/04 Newbury Pharmaceuticals AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 CI
22/02 Newbury Pharmaceuticals Secures SEK9 Million Sales Order MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Newbury Pharmaceuticals Secures Generic Approval for Liraglutide Pre-Filled Pen
AQ
Newbury Pharmaceuticals is strengthening its portfolio with Dalbavancin Powder
AQ
Newbury Pharmaceuticals Q2 - A bump in the road
AQ
Newbury Pharmaceuticals interim report September 2023 – February 2024
AQ
Newbury Pharmaceuticals carries out a directed share issue of approximately SEK 19 million
AQ
Newbury Pharmaceuticals receives international sales order valued at 8.8 million SEK
AQ
Nintedanib Newbury approved by the Swedish Health Authorities
AQ
Newbury Pharmaceuticals Q1 Report - Ramp-up in sales
AQ
ANNUAL GENERAL MEETING OF SHAREHOLDERS IN NEWBURY PHARMACEUTICALS AB
AQ
Newbury Pharmaceuticals interim report September 2023 – November 2023
AQ
Newbury Pharmaceuticals publishes its annual report for 2022/2023
AQ
Kallelse till årsstämma i Newbury Pharmaceuticals AB
AQ
Newbury Pharmaceuticals is strengthening its portfolio with Melatonin Extended Release 2 mg
AQ
Newbury Pharmaceuticals Q4 Report - Bolstered business
AQ
Newbury Pharmaceuticals year-end report September 2022 – August 2023
AQ
Newbury Pharmaceuticals has entered into a partnership granting access to 6 registered products.
AQ
Newbury Pharmaceuticals is strengthening its portfolio with Levodopa/Benserazide
AQ
Newbury Pharmaceuticals AB has successfully signed a 15 MSEK loan agreement
AQ
Newbury gains access to the Nordic hospital market with a new strategic partnership for prescription medicine
AQ
Desmopressin Newbury approved by the Swedish Health Authorities
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NEWBRY Stock
  4. News Newbury Pharmaceuticals AB
  5. Press Releases